Trials / Completed
CompletedNCT06062329
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Imperative Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism
Detailed description
SYMPHONY-PE is a pivotal study intended to assess the safety and efficacy of the Symphony Thrombectomy System to treat subjects with acute pulmonary embolism.
Conditions
- Acute Pulmonary Embolism
- Thromboembolism
- Emboli, Pulmonary
- Thrombosis
- Thrombus; Embolism
- Embolism
- Cardiovascular Diseases
- Vascular Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Symphony Thrombectomy System | The Symphony Thrombectomy System will be used to restore blood flow to the pulmonary arteries by removing thrombus/embolus/clot using aspiration and mechanical clot engagement. |
Timeline
- Start date
- 2023-12-13
- Primary completion
- 2025-05-04
- Completion
- 2025-05-29
- First posted
- 2023-10-02
- Last updated
- 2025-07-15
Locations
19 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06062329. Inclusion in this directory is not an endorsement.